Skip to main content
. 2020 Sep 7;91(3):e2020008. doi: 10.23750/abm.v91i3.10217

Table 3.

Characteristics of studies included in the neutrophilia analysis cohort

Study Country & City Sample Size Cut-off (x10*9/l) Severe patients Non-severe patients
n (%) Age (yrs)* Women (%) Neutrophilia
n (%)
n (%) Age (yrs)* Women (%) Neutrophilia
n (%)
Liu et al. [11] Shenzen, China 12 6 6 (50%) 64 3 (50%) 1 (16.7%) 6 (50%) 43.3 1 (16%) 1 (16.7%)
Zhang Gemin et al. [30] Wuhan, China 95 7 32 (33.7%) 50.5 (38.3-58.8) 11 (34.4%) 26 (81.3%) 63 (66.3%) 49 (41-57) 31 (49.2%) 4 (6.3%)
Li X et al. [23] Wuhan, China 548 6.5 267 (48.7%) 65 (54-72) 116 (43.1%) 96 (40%) 275 (50.1%) 56 (44-66) 153 (54.8%) 22 (8%)
Aggarwal et al. [25] Iowa, US 16 6.3 8 (50%) 67 (38-70) 3 (38%) 4 (50%) 8 (50%) 68.5 (41-95) 1 (13%) 2 (25%)
Survivors Non-survivors
n (%) Age (yrs)* Women (%) Neutrophilia
n (%)
n (%) Age (yrs)* Women (%) Neutrophilia
n (%)
Chen T et al., [27] Wuhan China 274 6.3 161 (58.8%) 51 (37-66) 73 (45%) 17 (10.6%) 113 (41.2%) 68 (62-77) 30 (27%) 75 (66.4%)
Bonetti et al., [29] Valcamonica, Italy 144 6.3 74 (51.4%) 62.1 (53-72.8) 24 (31.1%) 14 (18.9%) 70 (48.6%) 78 (64.2-84) 25 (35.7%) 32 (45.7%)